Psychedelic therapy Psychedelic therapy Psychedelic therapy refers to therapeutic practices involving psychedelic drugs, oftentimes utilizing serotonergic psychedelics such as LSD, psilocybin, DMT, MDMA, mescaline, and 2C-B. Psychedelic therapy, in contrast to conventional psychiatric medication taken by the patient regularly or as-needed, patients generally remain in an extended psychotherapy session during the acute psychedelic activity with additional sessions both before and after in order to help integrate experiences with the drug. Psychedelic therapy, in the broadest possible sense of the term, may have originated from prehistoric knowledge of hallucinogenic plants. They grow naturally in certain cacti, seeds, bark and roots of various plants.
4,5-Dihydroxy-2,3-pentanedione 4,5-Dihydroxy-2,3-pentanedione 4,5-Dihydroxy-2,3-pentanedione (DPD) is an organic compound that occurs naturally but exists as several related structures. The idealized formula for this species is CHC(O)C(O)CH(OH)CHOH, but it is known to exist as several other forms resulting from cyclization. It is not stable at room temperature as a pure material, which has further complicated its analysis. The ("S")-stereoisomer occurs naturally. It is typically hydrated, i.e., one keto group has added water to give the geminal diol. DPD is produced by degradation of "S"-adenosylhomocysteine by the action of the enzyme "S"-ribosylhomocysteinase. The compound probably does not exist as depicted above, but as an